Analysis of the impact of serpatinib on liver health
Serpatinib, as a targeted therapy for cancers related toRET gene mutations, its impact on liver health is a matter of close concern to both patients and doctors.
During the use of serpatinib, some patients may experience elevated liver enzyme levels. This increase in liver enzymes may be one of the direct effects of the drug on the liver. According to clinical data, the elevation of AST (aspartate aminotransferase) and ALT (alanine aminotransferase) is a relatively common phenomenon. Elevations in these liver enzymes may reflect liver cell damage or dysfunction.
In addition to elevations in liver enzymes, serpatinib may cause broader liver function abnormalities. Some patients have reported abnormal liver function symptoms, including jaundice, after using this drug. The appearance of jaundice is often associated with a decrease in the liver's ability to process bilirubin, which may be another sign of a drug's effect on liver function.
One of the more serious potential effects of serpatinib use is hepatotoxicity. This means the drug may cause substantial damage to the liver. Manifestations of hepatotoxicity may include severe liver function abnormalities, hepatocellular necrosis, etc. If a patient develops signs of hepatotoxicity while taking serpatinib, such as significant liver enzyme elevations or jaundice, doctors will often recommend reducing the dose of the drug or even permanently discontinuing it to prevent further liver damage.
Due to the potential effects of serpatinib on liver health, patients taking this drug need to have their liver function monitored closely. This usually includes regular blood tests to assess liver enzyme levels and other measures of liver function. Doctors will adjust treatment plans based on these monitoring results to ensure the safety and effectiveness of drug use.
Patients should maintain good living habits while taking serpatinib, including avoiding alcohol, maintaining adequate sleep, and exercising appropriately to reduce the burden on the liver.
References:
https://www.medicalnewstoday.com/articles/drugs-retevmo-side-effects
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)